
The ACMA MedicalAffairsLeadershipSummit returns on April 30, 2026, following a sold-out event in 2025 that left Medical Affairs & MSL Industry Leaders wanting more.
This one-day, in-person event exclusively brings together exclusive top executives and visionary Medical Affairs leaders across the Pharmaceutical and Life Sciences Industries.
Get real-world insights into challenges and innovations shaping our industry and strategies that truly make a measurable impact.
Build powerful peer relationships with executives from leading companies in an environment designed for connection and collaboration.
An event specifically curated and designed for maximum value with actionable outcomes.
"Absolutely the most relevant, high-impact Medical Affairs event I've attended all year."
"The speaker lineup was world-class. Every session delivered value."
"This wasn't just a conference, it was a leadership experience."
Robert Laudadio, Director of Strategic Marketing & Partnerships | Tel: 201.819.6145 | Email: robert.laudadio@acmainfo.org

Come away with real-world insights and strategies that will make an impact in your partnerships. Each session is comprised of 20 minute didactic presentation and 30 minute interactive exchange
Dr. David Fajgenbaum, physician-scientist, best-selling author of Chasing My Cure, and Co-Founder of Every Cure, shares his journey from a patient given last rites five times to a leader reshaping how rare diseases are treated. By turning personal adversity into scientific discovery, he pioneered a path to curing his own Castleman disease and now leads efforts to unlock treatments for overlooked conditions. In this keynote, Dr. Fajgenbaum challenges Medical Affairs professionals to adopt the same relentless mindset: executing a mission to drive meaningful change for patients.
This session explores how Medical Affairs teams navigate high-stakes crises from drug safety events and misinformation outbreaks to organizational restructures and operational disruption. Panelists will share real-world examples of managing both external and internal reputational threats while preserving scientific credibility, patient trust, and regulatory alignment. Attendees will gain actionable frameworks to proactively prepare their teams, communicate with transparency, and recover stronger
Attendees can share their distinct case examples and engage experts for precise, case-based recommendations.
Is your medical affairs team speaking the language of executives? This panel discussion brings leaders who have successfully championed Medical Affairs at the enterprise level to discuss how strategy is shaped, funded, and defended within the C-suite. Gain an inside look into how Medical Affairs is viewed from leadership and how to build alignment and credibility at the highest level.
Participants get to connect one-on-one with speakers to address their own case situations and obtain targeted solutions.
With the volume of scientific data accelerating, traditional education models can no longer keep pace with evolving HCP needs. This session introduces agentic AI, multi-agent systems (MAS) and systems of agent networks (SAN) that streamline evidence assessment, content creation, and omnichannel delivery.
Recognizing exceptional contributions to innovation, leadership, and impact in medical affairs.
Shifting policies, payer pressures, and geopolitical shifts continue to redefine evidence expectations, communication standards, and field engagement rules. This session unpacks the latest regulatory and political forces shaping Medical Affairs strategy.
Participants to discuss individual cases with panelists and receive specific, personalized feedback.
Can Medical Affairs be used as an economic signal? Engage with a learning healthcare equity analyst that will break down how institutional investors and Wall Street evaluate pharmaceutical/biotech companies and their Medical Affairs indicators, to predict performance
Participants can pose their case-specific questions to the speakers for focused, individualized guidance.
Dr. David Fajgenbaum, physician-scientist, best-selling author of Chasing My Cure, and Co-Founder of Every Cure, shares his journey from a patient given last rites five times to a leader reshaping how rare diseases are treated. By turning personal adversity into scientific discovery, he pioneered a path to curing his own Castleman disease and now leads efforts to unlock treatments for overlooked conditions. In this keynote, Dr. Fajgenbaum challenges Medical Affairs professionals to adopt the same relentless mindset: executing a mission to drive meaningful change for patients.
This session explores how Medical Affairs teams navigate high-stakes crises from drug safety events and misinformation outbreaks to organizational restructures and operational disruption. Panelists will share real-world examples of managing both external and internal reputational threats while preserving scientific credibility, patient trust, and regulatory alignment. Attendees will gain actionable frameworks to proactively prepare their teams, communicate with transparency, and recover stronger
Attendees can share their distinct case examples and engage experts for precise, case-based recommendations.
Is your medical affairs team speaking the language of executives? This panel discussion brings leaders who have successfully championed Medical Affairs at the enterprise level to discuss how strategy is shaped, funded, and defended within the C-suite. Gain an inside look into how Medical Affairs is viewed from leadership and how to build alignment and credibility at the highest level.
Participants get to connect one-on-one with speakers to address their own case situations and obtain targeted solutions.
With the volume of scientific data accelerating, traditional education models can no longer keep pace with evolving HCP needs. This session introduces agentic AI, multi-agent systems (MAS) and systems of agent networks (SAN) that streamline evidence assessment, content creation, and omnichannel delivery.
Recognizing exceptional contributions to innovation, leadership, and impact in medical affairs.
Shifting policies, payer pressures, and geopolitical shifts continue to redefine evidence expectations, communication standards, and field engagement rules. This session unpacks the latest regulatory and political forces shaping Medical Affairs strategy.
Participants to discuss individual cases with panelists and receive specific, personalized feedback.
Can Medical Affairs be used as an economic signal? Engage with a learning healthcare equity analyst that will break down how institutional investors and Wall Street evaluate pharmaceutical/biotech companies and their Medical Affairs indicators, to predict performance
Participants can pose their case-specific questions to the speakers for focused, individualized guidance.
Robert Laudadio, Director of Strategic Marketing & Partnerships | Tel: 201.819.6145 | Email: robert.laudadio@acmainfo.org
The ACMA Medical Affairs Leadership Summit 2026 offers an exclusive sponsorship opportunity limited to just six industry partners. Unlike traditional events, sponsors will not be separated in a distant exhibit hall, instead, they'll be embedded directly into the main event space, side-by-side with attendees and speakers for the full day.
This is more than visibility- it's strategic immersion. Sponsors will walk away not just with leads, but with lasting connections, competitive intelligence, and direct access to the people shaping industry standards.
Spots are extremely limited. Secure your presence at the forefront of Medical Affairs innovation.
Contact: Robert Laudadio, Director of Strategic Marketing & Partnerships
Telephone: 201 819 6145
Email: robert.laudadio@acmainfo.org
